Risk stratification after acute myocardial infarction by amplitude-frequency mapping of cyclic variation of heart

Junichiro Hayano1, Norihiro Ueda1, Masaya Kisohara1

  • 1Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Insights

Reduced heart rate variation predicts mortality after heart attack. Incorporating sleep apnea severity improves this prediction, enhancing risk assessment for patients post-acute myocardial infarction (AMI).

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Data Science

Background:

  • Blunted cyclic variation of heart rate (CVHR) amplitude (Acv) predicts mortality post-acute myocardial infarction (AMI).
  • Mild sleep apnea with mild O2 desaturation can also reduce Acv.
  • The study investigates if sleep apnea severity influences Acv's predictive power for post-AMI mortality.

Purpose of the Study:

  • To enhance the predictive accuracy of Acv for mortality risk after AMI.
  • To evaluate the impact of sleep apnea severity on Acv's prognostic value.
  • To develop a method for adjusting Acv based on sleep apnea severity.

Main Methods:

  • Utilized 24-hr ECG data from 265,291 participants in the Allostatic State Mapping by Ambulatory ECG Repository (ALLSTAR) project.
  • Estimated sleep apnea severity using the frequency of CVHR (Fcv) via an automated ACAT algorithm.
  • Modeled Acv distribution against Fcv using percentile regression and developed a function to convert Acv to a percentile value.

Main Results:

  • Low Acv values were more prevalent with lower Fcv in ALLSTAR data.
  • In the ENRICHD cohort (673 survivors, 44 non-survivors post-AMI), logistic regression showed improved c-statistics for mortality prediction: Fcv (0.667), unadjusted Acv (0.817), and percentile Acv (0.843).
  • Percentile Acv demonstrated a significant net reclassification improvement of 0.90 (95% CI, 0.51-1.42) compared to unadjusted Acv.

Conclusions:

  • The predictive power of Acv for post-AMI mortality is significantly improved by considering its relationship with sleep apnea severity, estimated by Fcv.
  • A novel percentile-based Acv calculation enhances prognostic accuracy.
  • This approach offers a more refined risk stratification for post-myocardial infarction patients potentially affected by sleep apnea.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
91
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
135
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
4.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
147